China is investigating the cost of medicines, probing as many as 60 domestic and international drugmakers.
The BBC reports the foreign firms involved include GlaxoSmithKline, Merck, Astellas and Baxter Healthcare.
The National Development and Reform Commission said it would look into the costs and pricing of the companies, so that drug prices can be adjusted in a timely manner.
